Semintra 10 mg/mL Oral Solution for Cats

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

telmisartan

Available from:

Boehringer Ingelheim Animal Health New Zealand Limited

Composition:

telmisartan 10 g/litre

Therapeutic area:

Renal & urinary tract modifier

Authorization date:

2020-06-24

Summary of Product characteristics

Product : Semintra 10 mg/mL Oral Solution for Cats
Date: 22 June 2023
ACVM No.: A011739
Page
1
of
7
VIAL LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Semintra
10 mg/mL Oral Solution for Cats
35 mL
ACTIVE CONSTITUENT:
10 mg/mL telmisartan
READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS
DIRECTIONS FOR USE
DOSAGE AND ADMINISTRATION
DISCARD UNUSED PRODUCT 6 MONTHS AFTER INITIAL USE.
SAFETY DIRECTIONS
Harmful if swallowed.
May irritate the eyes, avoid contact with eyes.
Wash hands after use.
FIRST AID
If poisoning occurs, contact a doctor or Poisons Information Centre.
Phone Australia 131126. New Zealand 0800 764 766 (0800 POISON)
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
Phone: [phone]
APVMA 86454/115796
NEW ZEALAND INFORMATION
RVM
PRECAUTION: The safety and efficacy of telmisartan for the management
of systemic
hypertension above 200 mmHg has not been investigated.
ACVM No. A011739
HSNO No. HSR100757
Boehringer Ingelheim Animal Health New Zealand Ltd
Freephone: 0800 800 822
Batch No.:
Expiry Date:
Product : Semintra 10 mg/mL Oral Solution for Cats
Date: 22 June 2023
ACVM No.: A011739
Page
2
of
7
CARTON LABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Semintra
10 mg/mL Oral Solution for Cats
10 mg/mL telmisartan
For the treatment of systemic hypertension in cats. For the reduction
of proteinuria in cats
with chronic kidney disease.
35 mL
READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS
DIRECTIONS FOR USE
DOSAGE AND ADMINISTRATION
DISCARD UNUSED PRODUCT 6 MONTHS AFTER INITIAL USE.
Administer orally once a day directly into the mouth or with a small
amount of food.
For the treatment of systemic hypertension in cats:
The initial recommended dose is 2 mg telmisartan/kg bodyweight (0.2
mL/kg bodyweight).
After 4 weeks, the dosage of telmisartan may be downtitrated in cats
with systolic blood
pressure (SBP) measurement lower than 1